W.J. Gullick
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research
- Pulmonary and Respiratory Medicine
- Co-authors
- Josephine C. AdamsMichael D. WaterfieldJulian DownwardThomas S. FrankBarbara L. WeberMary CoddM O'ReganAmanda McCann
- Topics
- HER2/EGFR in Cancer Research (11 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Glycosylation and Glycoproteins Research (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
W.J. Gullick
17 papers receiving 861 citations
Peers
Comparison fields: 5 of 71
- Oncology 578
- Molecular Biology 448
- Radiology, Nuclear Medicine and Imaging 273
- Cancer Research 154
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by W.J. Gullick
This map shows the geographic impact of W.J. Gullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.J. Gullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.J. Gullick more than expected).
Fields of papers citing papers by W.J. Gullick
This network shows the impact of papers produced by W.J. Gullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.J. Gullick. The network helps show where W.J. Gullick may publish in the future.
Co-authorship network of co-authors of W.J. Gullick
This figure shows the co-authorship network connecting the top 25 collaborators of W.J. Gullick. A scholar is included among the top collaborators of W.J. Gullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.J. Gullick. W.J. Gullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 2 | |
| 3 | Cripto-1 is a tumour specific marker of bladder cancer | 1 |
| 4 | 31 | |
| 5 | 72 | |
| 6 | 3 | |
| 7 | 29 | |
| 8 | Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques. | 49 |
| 9 | 31 | |
| 10 | Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. | 148 |
| 11 | 29 | |
| 12 | 87 | |
| 13 | Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. | 152 |
| 14 | 31 | |
| 15 | 21 | |
| 16 | 89 | |
| 17 | 97 |
About W.J. Gullick
W.J. Gullick is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 17 papers that have together received 883 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Oncology (578 citations), Radiology, Nuclear Medicine and Imaging (273 citations) and Cancer Research (154 citations). W.J. Gullick has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Josephine C. Adams, Michael D. Waterfield, Julian Downward, Thomas S. Frank, Barbara L. Weber, Mary Codd, M O'Regan, Amanda McCann, D N Carney and P. Dervan. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.